These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 142464)

  • 1. [Evaluation of verapamil in the treatment of idiopathic cardiac hypertrophy].
    Sekeff JA; Perez VP; Freitas LB; Dohmann HJ
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():49-54. PubMed ID: 142464
    [No Abstract]   [Full Text] [Related]  

  • 2. [Width and cross section of epicardial coronary arteries in relation to myocardial hypertrophy].
    Kober G; Spahn G; Becker HJ; Kaltenbach M
    Z Kardiol; 1974 Apr; 63(4):297-310. PubMed ID: 4277967
    [No Abstract]   [Full Text] [Related]  

  • 3. Co-existing aortic stenosis and secondary hypertrophic cardiomyopathy manifested by an hourglass left ventricle. Successful treatment with verapamil.
    Hasin Y; Rod JL; Friedman G
    Chest; 1979 Aug; 76(2):232-4. PubMed ID: 156629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of verapamil on diastolic left ventricular function in myocardial hypertrophy of different origin.
    Hess OM; Murakami T; Krayenbühl HP
    Z Kardiol; 1987; 76 Suppl 3():82-6. PubMed ID: 2963452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of hypertrophic obstructive cardiomyopathy using verapamil].
    Hopf R; Keller M; Kaltenbach M
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1054-7. PubMed ID: 1029919
    [No Abstract]   [Full Text] [Related]  

  • 6. Verapamil for refractory ventricular fibrillation during cardiac operations in patients with cardiac hypertrophy.
    Fyke FE; Vlietstra RE; Danielson GK; Beynen FM
    J Thorac Cardiovasc Surg; 1983 Jul; 86(1):108-11. PubMed ID: 6223184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective effect of verapamil in myocardial hypertrophy due to aortic stenosis experimentally induced in the rat].
    D'Ascia C; Picardi G; Picardi A; Marullo L; Romano M; Vitagliano G; Saccà L
    Cardiologia; 1988 Feb; 33(2):201-5. PubMed ID: 2965984
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of verapamil in the treatment of ventricular extrasystole in chronic Chagas' heart disease].
    Vichi FL; Nobre F; Evora P; Ribeiro PJ; Papa MV
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():101-6. PubMed ID: 407891
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pre- and postoperative study of myocardial hypertrophy and left ventricular function in adult aortic valve stenosis].
    Fechner J; Drobinski G; Eugène M; Kin G; Evans J; Bejean-Lebuisson A; Grosgogeat Y
    Ann Med Interne (Paris); 1982; 133(8):538-43. PubMed ID: 6221682
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of arrhythmias with verapamil].
    Castaño Bazo L; Pabón Osuna P; Sala Sánchez-Castillo A; Martin Luengo C; Ledesma García C
    Rev Clin Esp; 1977 Jun; 145(5):353-6. PubMed ID: 327515
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium antagonist treatment in mild forms of cardiomyopathy.
    Sievert H; Kunkel B; Wirtz M; Hopf R; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():164-6. PubMed ID: 3433871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contractility of the left ventricle in aortic valve stenosis; significance of myocardial hypertrophy].
    Hess OM; Brunner HH; Goebel NH; Krayenbühl HP
    Verh Dtsch Ges Kreislaufforsch; 1976; 42():152-5. PubMed ID: 1007558
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac hyperfunction and insufficiency in experimental valvular lesions.
    Markovskaya GI; Solov'ev VV; Shenderov SM; Gorbachenkov AA; Mdinaradze YS; Zargarli FI; Mikoelyan AL; Shul'zhenko EB
    Fed Proc Transl Suppl; 1966; 25(4):615-8. PubMed ID: 5223502
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of the renin-angiotensin system in the development of left ventricular hypertrophy--effect of ACE inhibition].
    Kromer EP
    Verh Dtsch Ges Inn Med; 1991; 97():558-62. PubMed ID: 1667052
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antia-angina effect of verapamil through the clinical and ergometric evaluation].
    Castro I; Pereira FA; Rodrigues R
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():75-7. PubMed ID: 329812
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-adrenergic blocking agents in hypertrophic cardiomyopathy (HOCM).
    Oakley CM
    Singapore Med J; 1973 Sep; 14(3):408-9. PubMed ID: 4149721
    [No Abstract]   [Full Text] [Related]  

  • 17. [Characteristics of coronary circulation in left ventricular hypertrophy secondary to aortic valve disease and dilated cardiomyopathy].
    Barsotti A; Mariotti R; Biadi O; Baglini R; Dini FL; Bertoli D; Ghelarducci B; Balbarini A; Mariani M
    Cardiologia; 1988 Feb; 33(2):183-90. PubMed ID: 2965983
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intravenous verapamil in hypertrophic myocardiopathy. A study using Doppler ultrasound].
    de la Morena Valenzuela G; Ruipérez Abizanda JA; Picó Aracil F; García García J; Jaén Armand E; Salas Nieto J
    Rev Esp Cardiol; 1990 May; 43(5):310-5. PubMed ID: 2144052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of successful, uncomplicated valve replacement on ventricular hypertrophy, volume, and performance in aortic stenosis and in aortic incompetence.
    Pantely G; Morton M; Rahimtoola SH
    J Thorac Cardiovasc Surg; 1978 Mar; 75(3):383-91. PubMed ID: 147370
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiomyopathies and their treatment].
    Halawa B; Mazurek W
    Wiad Lek; 1980 May; 33(9):707-13. PubMed ID: 6447410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.